Welcome to the Immudex Blog
At Immudex our mission is to help researchers and clinicians unravel the complexity of the immune system, enabling the development of more effective immune-based therapeutics and diagnostics.
Through this blog, we hope to share some of the insights that we’ve gained from over a decade of working with antigen specificity and precision immune monitoring.
Troubleshooting Flow Cytometry
COVID-19
Checkpoint Inhibitors
TCR-T Cell Therapy
Release Testing of TCR-T Cell Therapies
TECELRA® (afami-cel) is the first TCR-T cell therapy for solid tumors to be approved by the U.S. FDA
First-in-human dose escalation trial of a MAGE-A1-directed TCR-T cell therapy for solid tumors
CAR-T Cell Therapy
CAR-T Staining Reagents: Avidity can make all the difference in detecting CAR-T cells
The Proof is in the Staining: A Comparison of CAR Detection Reagents
Cancer Vaccines
Simultaneous Analysis of Multiple Immune Cell Types in One Workflow
Multicolor Flow Cytometry
B Cells
Epitope Discovery and Validation
pMHC Binding Affinity
What Tools Are Available to Predict Peptide-MHC Binding Affinity?
Factors Contributing to Immunogenicity and pMHC Complex Binding Affinity